comparemela.com

Latest Breaking News On - Daniel salain - Page 1 : comparemela.com

Idera Bolsters Rare Disease Portfolio with Aceragen Buyout

Two rare disease companies - Idera Pharmaceuticals and Aceragen - are merging to pursue the common goal of an FDA approval that could come as early as 2024.

United statesJohn taylorCarl krausJohn kirbyDaniel salainUs defense threat reduction agencyIdera pharmaceuticalsFast trackQualified infectious disease productThreat reduction agencyChief medical officer carl krausChief operating officer danielGeneral counsel bryant limChief financial officer john kirbyNovaquest the durhamDera bolsters rare disease portfolio with aceragen buyout

Idera Pharma (IDRA) Acquires Aceragen

Idera Pharma (IDRA) Acquires Aceragen
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomJames geraghtyRon wootenCarl krausDaniel salainMaxine gowenMichael doughertyJohn taylorWedbush pacgrowCandy jordanCristina csimmaJohn kirbyFarber diseaseIdera pharmaceuticals incFenwick west

vimarsana © 2020. All Rights Reserved.